filgotinib to phase 3 in ibd read the press release welcome to galapagos galapagos is a clinical stage biotechnology company specialized in the discovery and development of small molecule medicines with novel modes of action . our ambition is to become a leading global biotechnology company focused on the development and commercialization of novel medicines that will improve people s lives . learn more about galapagos news all galapagos news events all galapagos events stock stock information shareholder information novel targets better treatments watch our target discovery animation . read more a lung transplant no way . thijs timmers 18 has cystic fibrosis . impossible does not exist in his dictionary . read more copyright 2016 galapagos nv disclaimer terms news via mail